zoledronic acid has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukai, J; Koizumi, F; Nakao, N | 1 |
| Biray Avci, C; Dodurga, Y; Elmas, L; Goker, B; Gunduz, C; Kurt, CC; Mutlu, Z; Ozalp, O; Tepedelen, BE | 1 |
2 other study(ies) available for zoledronic acid and Glioma
| Article | Year |
|---|---|
Enhanced anti-tumor effect of zoledronic acid combined with temozolomide against human malignant glioma cell expressing O6-methylguanine DNA methyltransferase.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Diphosphonates; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Imidazoles; Mice; O(6)-Methylguanine-DNA Methyltransferase; ras Proteins; Signal Transduction; Temozolomide; Xenograft Model Antitumor Assays; Zoledronic Acid | 2014 |
Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells.
Topics: Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Cell Line, Tumor; Cell Survival; Diphosphonates; DNA Fragmentation; Endoribonucleases; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Humans; Imidazoles; Interferon Regulatory Factors; Protein Serine-Threonine Kinases; Toll-Like Receptor 2; Zoledronic Acid | 2016 |